The addition of GST-ARG1 leads to cell growth inhibition in most of the cells in a concentration-dependent manner, with pancreatic, breast, ovarian and lung cancer cells displaying, as a whole, a higher sensitivity to arginine depletion. Here, ARG1 is linked to lung carcinoma.